Kevin DAmour - Jun 28, 2021 Form 3 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Signature
/s/Bella Zaslavsky, Attorney-in-Fact for Kevin D'Amour
Stock symbol
ERNA
Transactions as of
Jun 28, 2021
Transactions value $
$0
Form type
3
Date filed
6/30/2021, 09:33 PM
Next filing
Mar 17, 2022

No securities are beneficially owned.

Remarks:

Chief Scientific Officer. Exhibit List: Exhibit 24 - Power of Attorney